Introduction to OARSI FDA initiative OAC special edition

Osteoarthritis and Cartilage

Volumn 19, Issue 5, 2011, Pages 475-477

  Abramson, S B ^a   Berenbaum, F ^b   Hochberg, M C ^c   Moskowitz, R W ^d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HÔPITAL SAINT ANTOINE   (France)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE; EDITORIAL; FOOD AND DRUG ADMINISTRATION; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; OSTEOARTHRITIS;

EID: 79955816816     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2010.12.013     Document Type: Editorial

References (2)

1. [accessed 10.05.10]. http://www.fda.gov/.../GuidanceComplianceRegulatoryInformation/Guidances/ucm071577.pdf.
2. Health and Human Services Department, Food and Drug Administration [Human drugs, biological products, and medical devices] [accessed 10.05.10]. http://www.access.gpo.gov/su_docs/fedreg/a070814c.html.